BIANCO, ROBERTO
BIANCO, ROBERTO
Dipartimento di Medicina clinica e Chirurgia
A phase II study of beweekly oxaliplatin plus infusional 5fluorouracil and folinic acid (FOLFOX4) as first-line treatment of advenced gastric cancer patients
2004 F., De Vita; M., Orditura; Matano, Elide; Bianco, Roberto; Carlomagno, Chiara; S., Infusino; Damiano, Vincenzo; E., Simeone; Mr, Diadema; E., Lieto; P., Castellano; S., Pepe; DE PLACIDO, Sabino; G., Galizia; F., Ciardiello; G., Catalano; Ar, Bianco
1599P - Effects of Hedgehog signaling inhibition on epithelial-stromal interactions in triple negative breast cancer cells
2014 Servetto, A.; Raimondo, L.; Formisano, L.; Marciano, R.; Di Mauro, C.; Rosa, R.; D'Amato, V.; Veneziani, BIANCA MARIA; DE PLACIDO, Sabino; Bianco, Roberto
Quality of Life Analysis of TORCH, a Randomized Trial Testing First-Line Erlotinib Followed by Second-Line Cisplatin/Gemcitabine Chemotherapy in Advanced Non-Small-Cell Lung Cancer.
2012 Di Maio, M.; Leighl, N. B.; Gallo, C.; Feld, R.; Ciardiello, F.; Butts, C.; Maione, P.; Gebbia, V.; Morgillo, F.; Wierzbicki, R.; Favaretto, A.; Alam, Y.; Cinieri, S.; Siena, S.; Bianco, Roberto; Riccardi, F.; Spatafora, M.; Ravaioli, A.; Felletti, R.; Fregoni, V.; Genestreti, G.; Rossi, A.; Mancuso, G.; Fasano, M.; Morabito, A.; Tsao, M. S.; Signoriello, S.; Perrone, F.; Gridelli, C.
Increased TGF-? as a Mechanism of Acquired Resistance to the Anti-EGFR Inhibitor Cetuximab through EGFR-MET Interaction and Activation of MET Signaling in Colon Cancer Cells
2013 T., Troiani; E., Martinelli; S., Napolitano; D., Vitagliano; L. P., Ciuffreda; S., Costantino; F., Morgillo; A., Capasso; V., Sforza; A., Nappi; R., De Palma; E., D'Aiuto; L., Berrino; Bianco, Roberto; F., Ciardiello
Toll-like receptor 9 agonist IMO cooperates with everolimus in renal cell carcinoma by interfering with tumour growth and angiogenesis.
2013 Damiano, Vincenzo; Rosa, Roberta; Formisano, Luigi; Nappi, Lucia; Gelardi, T.; Marciano, Roberta; Cozzolino, I.; Troncone, Giancarlo; Agrawal, S.; Veneziani, BIANCA MARIA; DE PLACIDO, Sabino; Bianco, Roberto; Tortora, G.
Antitumor activity of ZD6474, a small molecule VEGF receptor tyrosine kinase inhibitor, in human cancer cells with acquired resistance to EGF receptor-targeted drugs.
2003 Ciardiello, F; Bianco, Roberto; Caputo, R; Caputo, R; Damiano, V; Veneziani, BIANCA MARIA; De Vita, F; DE PLACIDO, Sabino; Bianco, Ar; Tortora, G.
INHIBITION OF CANCER CELL GROWTH AND INVASION BY TARGETING C-SRC IN BREAST CANCER MODELS RESISTANT TO ANTI-HER2 DRUGS
2011 Formisano, L.; Damiano, V.; Nappi, L.; Rosa, R.; Gelardi, T.; D’Amato, C.; Marciano, R.; De Maio, A. P.; Ferrara, R.; Tortora, G.; Veneziani, BIANCA MARIA; DE PLACIDO, Sabino; Bianco, Roberto
Enhancement of antitumor activity of ionizing radiation by combined treatment with the selective epidermal growth factor receptor-tyrosine kinase inhibitor ZD1839 (Iressa).
2002 Cataldo, Bianco; Giampaolo, Tortora; Bianco, Roberto; Roberta, Caputo; Veneziani, BIANCA MARIA; Rosa, Caputo; Vincenzo, Damiano; Teresa, Troiani; Gabriella, Fontanini; David, Raben; Stefano, Pepe; A., Raffaele Bianco; Fortunato, Ciardiello
High-rsolution melting analysis (HRMA) for KRAS mutatiinal study in patients with metastatic colorectal cancer (mCRC pts)
2012 De Stefano, A; Malapelle, Umberto; Carlomagno, Chiara; Bianco, Roberto; Marciano, Roberta; Cimminiello, C; Colantuoni, M; DE PLACIDO, Sabino; Troncone, Giancarlo
Targeting SRC tyrosine kinase to overcome resistance to HER-inhibitors in humancancer
2011 Bianco, Roberto
Mechanisms of resistance development against trastuzumab (Herceptin) in an in vivo breast cancer model.
2004 Ritter, Ca; Bianco, Roberto; Dugger, T; Forbes, J; Qu, S; Rinehart, C; King, W; Arteaga, Cl
Addition of erlotinib to fluoropyrimidine-oxaliplatin-basedchemotherapy with or without bevacizumab: Two sequential phase I trials
2011 Carlomagno, Chiara; Gennaro, Daniele*; Bianco, Roberto; Marciano, Roberta; Damiano, Vincenzo; Elide, Matano; Nappi, Lucia; Stefano, Pepe; DE PLACIDO, Sabino; Giampaolo, Tortora
A novel mdm2 antisense oligonucleotide has antitumor activity and potentiates cytotoxic drugs acting by different mechanisms in human colon cancer.
2000 Tortora, Giampaolo; Caputo, R; Damiano, Vincenzo; Bianco, Roberto; Chen, J; Agrawal, S; Bianco, Ar; Ciardiello, F.
Enzastaurin inhibits tumors sensitive and resistant to anti-EGFR drugs
2008 Gelardi, Teresa; Caputo, R; Damiano, Vincenzo; Daniele, Gennaro; Pepe, Stefano; Ciardiello, F; Lahn, M; Bianco, Roberto; Tortora, Giampaolo
Combined blockade of PKA and bcl-2 by antisense strategy induces apoptosis and inhibits tumor growth and angiogenesis.
2001 Tortora, Giampaolo; Caputo, R; Damiano, Vincenzo; Bianco, Roberto; Fontanini, G; Cuccato, S; DE PLACIDO, Sabino; Bianco, Ar; Ciardiello, F.
VEGF Receptor 1 contributes to resistance to anti-EGFR drugs in human cancer cells.
2008 Bianco, Roberto; Rosa, R; Damiano, V; Daniele, G; Gelardi, T; Garofalo, S; Tarallo, V; De Falco, S; Melisi, D; Benelli, R; Albini, A; Ryan, A; Ciardiello, F; Tortora, Giampaolo
Oral antisense targeting protein kinase A cooperates with taxol and inhibits tumor growth, angiogenesis and growth factors production.
2000 Tortora, Giampaolo; Bianco, Roberto; Damiano, Vincenzo; Fontanini, G; DE PLACIDO, Sabino; Bianco, Ar; Ciardiello, F.
Zoledronic acid cooperates with a cyclooxygenase-2 inhibitor and gefitinib in inhibiting breast and prostate cancer.
2005 Melisi, Davide; Caputo, R; Damiano, Vincenzo; Bianco, Roberto; Veneziani, BIANCA MARIA; Bianco, Ar; DE PLACIDO, Sabino; Ciardiello, F; Tortora, Giampaolo
Inhibition of mTOR pathway by everolimus cooperates with EGFR inhibitors in human tumors sensitive and resistant to anti-EGFR drugs
2008 Bianco, Roberto; Garofalo, S; Rosa, R; Damiano, V; Gelardi, T; Daniele, G; Ciardiello, F; Tortora, Giampaolo
P0081 Src inhibitors act through different mechanisms to cooperate with EGFR or MEK inhibitors in NSCLC models sensitive or resistant to erlotinib
2014 Raimondo, L.; Formisano, L.; Rosa, R.; D?amato, C.; D?amato, V.; Nappi, L.; Marciano, R.; Di Mauro, C.; Servetto, A.; Damiano, V.; Veneziani, BIANCA MARIA; DE PLACIDO, Sabino; Bianco, Roberto
| Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|---|
| A phase II study of beweekly oxaliplatin plus infusional 5fluorouracil and folinic acid (FOLFOX4) as first-line treatment of advenced gastric cancer patients | 1.5 Abstract in rivista | 2004 | F., De Vita; M., Orditura; Matano, Elide; Bianco, Roberto; Carlomagno, Chiara; S., Infusino; Damiano, Vincenzo; E., Simeone; Mr, Diadema; E., Lieto; P., Castellano; S., Pepe; DE PLACIDO, Sabino; G., Galizia; F., Ciardiello; G., Catalano; Ar, Bianco | |
| 1599P - Effects of Hedgehog signaling inhibition on epithelial-stromal interactions in triple negative breast cancer cells | 1.5 Abstract in rivista | 2014 | Servetto, A.; Raimondo, L.; Formisano, L.; Marciano, R.; Di Mauro, C.; Rosa, R.; D'Amato, V.; Veneziani, BIANCA MARIA; DE PLACIDO, Sabino; Bianco, Roberto | |
| Quality of Life Analysis of TORCH, a Randomized Trial Testing First-Line Erlotinib Followed by Second-Line Cisplatin/Gemcitabine Chemotherapy in Advanced Non-Small-Cell Lung Cancer. | 1.1 Articolo in rivista | 2012 | Di Maio, M.; Leighl, N. B.; Gallo, C.; Feld, R.; Ciardiello, F.; Butts, C.; Maione, P.; Gebbia, V.; Morgillo, F.; Wierzbicki, R.; Favaretto, A.; Alam, Y.; Cinieri, S.; Siena, S.; Bianco, Roberto; Riccardi, F.; Spatafora, M.; Ravaioli, A.; Felletti, R.; Fregoni, V.; Genestreti, G.; Rossi, A.; Mancuso, G.; Fasano, M.; Morabito, A.; Tsao, M. S.; Signoriello, S.; Perrone, F.; Gridelli, C. | |
| Increased TGF-? as a Mechanism of Acquired Resistance to the Anti-EGFR Inhibitor Cetuximab through EGFR-MET Interaction and Activation of MET Signaling in Colon Cancer Cells | 1.1 Articolo in rivista | 2013 | T., Troiani; E., Martinelli; S., Napolitano; D., Vitagliano; L. P., Ciuffreda; S., Costantino; F., Morgillo; A., Capasso; V., Sforza; A., Nappi; R., De Palma; E., D'Aiuto; L., Berrino; Bianco, Roberto; F., Ciardiello | |
| Toll-like receptor 9 agonist IMO cooperates with everolimus in renal cell carcinoma by interfering with tumour growth and angiogenesis. | 1.1 Articolo in rivista | 2013 | Damiano, Vincenzo; Rosa, Roberta; Formisano, Luigi; Nappi, Lucia; Gelardi, T.; Marciano, Roberta; Cozzolino, I.; Troncone, Giancarlo; Agrawal, S.; Veneziani, BIANCA MARIA; DE PLACIDO, Sabino; Bianco, Roberto; Tortora, G. | |
| Antitumor activity of ZD6474, a small molecule VEGF receptor tyrosine kinase inhibitor, in human cancer cells with acquired resistance to EGF receptor-targeted drugs. | 1.5 Abstract in rivista | 2003 | Ciardiello, F; Bianco, Roberto; Caputo, R; Caputo, R; Damiano, V; Veneziani, BIANCA MARIA; De Vita, F; DE PLACIDO, Sabino; Bianco, Ar; Tortora, G. | |
| INHIBITION OF CANCER CELL GROWTH AND INVASION BY TARGETING C-SRC IN BREAST CANCER MODELS RESISTANT TO ANTI-HER2 DRUGS | 1.5 Abstract in rivista | 2011 | Formisano, L.; Damiano, V.; Nappi, L.; Rosa, R.; Gelardi, T.; D’Amato, C.; Marciano, R.; De Maio, A. P.; Ferrara, R.; Tortora, G.; Veneziani, BIANCA MARIA; DE PLACIDO, Sabino; Bianco, Roberto | |
| Enhancement of antitumor activity of ionizing radiation by combined treatment with the selective epidermal growth factor receptor-tyrosine kinase inhibitor ZD1839 (Iressa). | 1.1 Articolo in rivista | 2002 | Cataldo, Bianco; Giampaolo, Tortora; Bianco, Roberto; Roberta, Caputo; Veneziani, BIANCA MARIA; Rosa, Caputo; Vincenzo, Damiano; Teresa, Troiani; Gabriella, Fontanini; David, Raben; Stefano, Pepe; A., Raffaele Bianco; Fortunato, Ciardiello | |
| High-rsolution melting analysis (HRMA) for KRAS mutatiinal study in patients with metastatic colorectal cancer (mCRC pts) | 1.5 Abstract in rivista | 2012 | De Stefano, A; Malapelle, Umberto; Carlomagno, Chiara; Bianco, Roberto; Marciano, Roberta; Cimminiello, C; Colantuoni, M; DE PLACIDO, Sabino; Troncone, Giancarlo | |
| Targeting SRC tyrosine kinase to overcome resistance to HER-inhibitors in humancancer | 8.07 Progetti di Ricerca Finanziati | 2011 | Bianco, Roberto | |
| Mechanisms of resistance development against trastuzumab (Herceptin) in an in vivo breast cancer model. | 1.1 Articolo in rivista | 2004 | Ritter, Ca; Bianco, Roberto; Dugger, T; Forbes, J; Qu, S; Rinehart, C; King, W; Arteaga, Cl | |
| Addition of erlotinib to fluoropyrimidine-oxaliplatin-basedchemotherapy with or without bevacizumab: Two sequential phase I trials | 1.1 Articolo in rivista | 2011 | Carlomagno, Chiara; Gennaro, Daniele*; Bianco, Roberto; Marciano, Roberta; Damiano, Vincenzo; Elide, Matano; Nappi, Lucia; Stefano, Pepe; DE PLACIDO, Sabino; Giampaolo, Tortora | |
| A novel mdm2 antisense oligonucleotide has antitumor activity and potentiates cytotoxic drugs acting by different mechanisms in human colon cancer. | 1.1 Articolo in rivista | 2000 | Tortora, Giampaolo; Caputo, R; Damiano, Vincenzo; Bianco, Roberto; Chen, J; Agrawal, S; Bianco, Ar; Ciardiello, F. | |
| Enzastaurin inhibits tumors sensitive and resistant to anti-EGFR drugs | 1.1 Articolo in rivista | 2008 | Gelardi, Teresa; Caputo, R; Damiano, Vincenzo; Daniele, Gennaro; Pepe, Stefano; Ciardiello, F; Lahn, M; Bianco, Roberto; Tortora, Giampaolo | |
| Combined blockade of PKA and bcl-2 by antisense strategy induces apoptosis and inhibits tumor growth and angiogenesis. | 1.1 Articolo in rivista | 2001 | Tortora, Giampaolo; Caputo, R; Damiano, Vincenzo; Bianco, Roberto; Fontanini, G; Cuccato, S; DE PLACIDO, Sabino; Bianco, Ar; Ciardiello, F. | |
| VEGF Receptor 1 contributes to resistance to anti-EGFR drugs in human cancer cells. | 1.1 Articolo in rivista | 2008 | Bianco, Roberto; Rosa, R; Damiano, V; Daniele, G; Gelardi, T; Garofalo, S; Tarallo, V; De Falco, S; Melisi, D; Benelli, R; Albini, A; Ryan, A; Ciardiello, F; Tortora, Giampaolo | |
| Oral antisense targeting protein kinase A cooperates with taxol and inhibits tumor growth, angiogenesis and growth factors production. | 1.1 Articolo in rivista | 2000 | Tortora, Giampaolo; Bianco, Roberto; Damiano, Vincenzo; Fontanini, G; DE PLACIDO, Sabino; Bianco, Ar; Ciardiello, F. | |
| Zoledronic acid cooperates with a cyclooxygenase-2 inhibitor and gefitinib in inhibiting breast and prostate cancer. | 1.1 Articolo in rivista | 2005 | Melisi, Davide; Caputo, R; Damiano, Vincenzo; Bianco, Roberto; Veneziani, BIANCA MARIA; Bianco, Ar; DE PLACIDO, Sabino; Ciardiello, F; Tortora, Giampaolo | |
| Inhibition of mTOR pathway by everolimus cooperates with EGFR inhibitors in human tumors sensitive and resistant to anti-EGFR drugs | 1.1 Articolo in rivista | 2008 | Bianco, Roberto; Garofalo, S; Rosa, R; Damiano, V; Gelardi, T; Daniele, G; Ciardiello, F; Tortora, Giampaolo | |
| P0081 Src inhibitors act through different mechanisms to cooperate with EGFR or MEK inhibitors in NSCLC models sensitive or resistant to erlotinib | 1.5 Abstract in rivista | 2014 | Raimondo, L.; Formisano, L.; Rosa, R.; D?amato, C.; D?amato, V.; Nappi, L.; Marciano, R.; Di Mauro, C.; Servetto, A.; Damiano, V.; Veneziani, BIANCA MARIA; DE PLACIDO, Sabino; Bianco, Roberto |